Latest Updates on COVID-19 Testing - Kits, Products, Service

JAVASCRIPT DISABLED - This site works best with JavaScript enabled.

« Previous article
Latest Updates on CO...

Next article »
Latest Updates on CO...

4th August 2020 Content supplied by: rapidmicrobiology.com

Latest Updates on COVID-19 Testing - Kits, Products, Services, Instrumentation - 4 Aug 2020

In this weeks COVID19 updates;

Microbiologics has expanded its custom virology solutions to include Biosafety Level 3 (BSL-3) antiviral services and launched a menu of cell-based services for SARS-CoV-2 to assist assay developers, evaluate therapeutic solutions and vaccines, and provide inactivated intact virus to researchers and diagnostic companies.

XPRIZE Rapid COVID Testing competition calls on the world’s brightest, most innovative minds to develop new, low-cost testing solutions that range from testing devices with 15-minute results to distributed lab testing methods with “next morning” results.

Passengers arriving into Paris Charles de Gaulle Airport are screened by thermal imaging cameras and those with a fever are given a rapid PCR test.

Two clinical trials find 100% diagnostic accuracy for Bruker's FluoroType® SARS-CoV-2 multiplex qPCR assay

A public health laboratory near New Dehli, India, has released data on its 'hotspot' COVID-19 testing regime which uses SD Biosensor's Standard Q COVID-19 Ag Kit to test 1200 samples per day.

We learn about COVID-SeroIndex test kit, an ELISA assay, designed to measure the presence or absence of anti-COVID-19 antibodies in addition to measuring the titer (level) of antibodies a person has produced.

And we hear how a Fortune 100 global consumer packaged goods company has introduced LabVantage COVID-19 LIMS solution to ensure employee health and safety in the workplace.

Microbiologics Expands Viral Capabilities for SARS-CoV-2 With New BSL-3 Laboratory

With new virology services capabilities, Microbiologics has launched a menu of cell-based services for SARS-CoV-2 to assist assay developers, evaluate therapeutic solutions and vaccines, and provide inactivated intact virus to researchers and diagnostic companies.
Find Out More

Competition Launched to Design Rapid COVID-19 Test

XPRIZE in collaboration with OpenCovidScreen has launched $5 million XPRIZE Rapid COVID testing competition to accelerate the development of high-quality COVID-19 testing that is low cost, easy to use, and fast-turnaround, enabling frequent testing.
Find Out More

Paris Airport Rapid PCR Testing Feverish Travellers

For the past month, the VitaPCR™ rapid test has been used on feverish passengers arriving at Roissy Airport. The test uses PCR to amplify a region within the nucleocapsid gene and provides airport authorities with a result within 20 minutes with just two minutes hands-on-time.
Find Out More

Two Clinical Trials Show 100% Diagnostic Accuracy for COVID-19 Multiplex qPCR Assay

Bruker's FluoroType^®SARS-CoV-2 multiplex qPCR assay has demonstrated 100% accuracy in two clinical trials. The test is CE-IVD marked, detects two regions on SARS-CoV-2, differentiates between 4 other coronaviruses and has been validated on common RT-PCR thermocyclers.
Find Out More

India Council Release Data on High Volume COVID-19 Antigen Testing Regime

SD Biosensor's Standard Q Ag rapid antigen test is now used as the first test to be deployed in hotspot areas as part of several country's testing regimes. The lateral-flow test gives a result within 15 minutes, and SD Biosensor has supplied 15 million kits to India over the last 3 weeks.
Find Out More

FDA Recommendations for COVID-19 Diagnostics for Use In Non-Lab Settings

The FDA has posted a new template for commercial developers to help them submit EUA requests for COVID-19 diagnostic tests that can be performed entirely at home or in other settings besides a lab, such as offices or schools, and that could be available without a prescription.
Find Out More

Quantitative RUO COVID-19 ELISA Will Help Vaccine Developers

COVID-SeroIndex test kit is an ELISA assay, designed to measure the presence or absence of anti-COVID-19 antibodies in addition to measuring the titer of antibodies a person has produced. It utilizes not one, but two virus antigens: the full-length spike protein, and its receptor binding domain.
Find Out More

LabVantage COVID-19 LIMS Solution Implemented for Onsite Workplace Health and Safety

The COVID-specific LIMS solution incorporates LabVantage’s deep knowledge of laboratory workflows, along with numerous features designed to make it easy for laboratories to perform coronavirus testing using RT-PCR, isothermal nucleic acid amplification, and serology methods.
Find Out More

Click here to explore our COVID-19 Test Method Guide with details of test kits, standards, and controls

Tags: